do not combine dpp-4 inhibitors with glp-1 receptor agonists guideline and GLP-1RAs: cardiovascular safety and benefits | Military Medical Research Frontiers | Clinical Use of

If it is almost time for your next dose, skip the missed one and continue with your regular schedule

Use With Caution / Additional Monitoring in Research Contexts Because GHK-Cu is researched for its interaction with regenerative, collagen-related, antioxidant-support, tissue-remodeling, and cellular-maintenance pathways, certain higher-frequency or complex experimental protocols may warrant additional monitoring and individualized evaluation

Monnier L, Lapinski H, Colette C

Patients and prescribers should consult the most current SmPC once available, alongside relevant NICE guidance, before initiating retatrutide alongside any existing medication regimen